|
|
||||||||
The Upjohn Company, 301 Henrietta Street, Kalamazoo, Michigan 49001, U.S.A.
The cotton rat model of experimental human respiratory syncytial virus (RSV) infection was used to study the efficacy of FG, a novel chimeric glycoprotein which was expressed in insect cells using a baculovirus vector. FG contained the extracellular regions of the F (fusion) and G (attachment) glycoproteins of RSV. Vaccination with FG resulted in induction of neutralizing antibody and was correlated with protection of lung tissue from RSV challenge against both serogroup A and B virus strains. Both crude FG taken from supernatants of insect cells and affinity-purified FG were immunogenic and active against RSV. FG vaccination was effective by three routes of administration, following a single dose, and when administered with different adjuvants.
Keywords: RSV, human, glycoprotein protection
Received 8 March 1989;
accepted 8 June 1989.
This article has been cited by other articles:
![]() |
G. A. Prince, C. Capiau, M. Deschamps, L. Fabry, N. Garçon, D. Gheysen, J.-P. Prieels, G. Thiry, O. Van Opstal, and D. D. Porter Efficacy and Safety Studies of a Recombinant Chimeric Respiratory Syncytial Virus FG Glycoprotein Vaccine in Cotton Rats J. Virol., November 15, 2000; 74(22): 10287 - 10292. [Abstract] [Full Text] |
||||
![]() |
W. M. Sullender Respiratory Syncytial Virus Genetic and Antigenic Diversity Clin. Microbiol. Rev., January 1, 2000; 13(1): 1 - 15. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |